Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,708,323
-$22,038,314 QoQ
Shares Held
50,502
-68.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#797
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OSSIAM holds $190,268,884 across 10 Drug Manufacturers - General names. ABBV ranks #4 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
90,300 | $108,308,538 | |
| 2 | AZN |
Astrazeneca PLC
|
80,256 | $15,218,142 | |
| 3 | AMGN |
Amgen Inc
|
36,294 | $13,142,783 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
50,502 | $12,708,323 | |
| 5 | MRK |
Merck & Co., Inc.
|
91,787 | $11,794,629 | |
| 6 | BIIB |
Biogen Inc.
|
39,223 | $8,474,521 | |
| 7 | PFE |
Pfizer Inc
|
275,753 | $6,640,132 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
49,573 | $6,263,052 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,708,323 | 50,502 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $34,746,637 | 159,762 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $13,917,325 | 60,910 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $7,490,319 | 32,350 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $51,750,670 | 278,799 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $10,157,948 | 48,482 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $7,002,623 | 39,407 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $60,248,778 | 305,088 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $10,011,965 | 58,372 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $10,684,353 | 58,673 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $9,174,843 | 59,204 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,894,366 | 52,961 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,719,187 | 35,027 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,017,492 | 37,758 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $6,606,940 | 40,882 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $23,758,525 | 177,025 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $24,067,562 | 157,140 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $47,107,869 | 290,592 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $49,065,033 | 362,371 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $15,080,118 | 139,799 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $16,932,608 | 150,325 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $34,110,511 | 315,196 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $12,114,379 | 113,060 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $10,186,892 | 116,302 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,302,480 | 33,637 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,498,041 | 32,787 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||